Self-testing Market Trends, Size, Growth Drivers, Analysis, Demand and Future Outlook

Self-testing Market Growth, Size, Trends Analysis - By Product, By Sample, By Application, By Distribution Channel - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Published: Mar-2025 Report ID: HLCA2584 Pages: 1 - 235 Formats*:     
Category : Healthcare
Self-testing Market Introduction and Overview

According to SPER Market Research, the Global Self-testing Market is estimated to reach USD 31.41 billion by 2034 with a CAGR of 6.95%.

The report includes an in-depth analysis of the Global Self-testing Market, including market size and trends, product mix, Applications, and supplier analysis. The self-testing market was valued at over USD 16.04 billion in 2024 and is expected to grow at a 6.95% CAGR from 2025 to 2034. Preventive healthcare, an increase in chronic diseases, an aging population, and the convenience and accessibility provided by self-testing kits are among the primary drivers driving market expansion. The expanding emphasis on preventative healthcare encourages people to check their health on a regular basis, increasing the need for self-testing as a proactive approach to well-being. Furthermore, the movement toward personalized treatment, which includes genetic testing and specific health recommendations, adds to the appeal of self-testing for individualized health insights.
By Product Insights: The kits segment led the market with a large revenue share in 2024 and is expected to grow the fastest during the forecast period. These kits provide convenience and are used for monitoring health conditions like pregnancy, diabetes, and infections at home. Innovations in accuracy, design, and distribution are driving this segment's growth, supported by key players' investments in R&D.

By Sample Insights: The blood sample segment led the market with the highest revenue share in 2024. This dominance is due to the rising use of blood samples for diagnostics, as they are non-invasive and provide detailed health insights. New product launches with advanced features are expected to boost segment growth.

By Application Insights: The allergy test application segment had the highest revenue share in 2024. The rising prevalence of allergy disorders is one of the important factors driving market growth over the predicted period.

By Distribution Channel Insights: The offline segment led the market in 2024, earning the largest revenue share. Companies are investing heavily in their distribution networks, which is expected to boost growth. More distribution agreements are also likely to help. This channel is crucial in areas with limited online access or for consumers wanting personal consultations, especially where regulations require direct contact with healthcare professionals.

Regional Insights: The self-testing market in North America led globally and held a significant revenue share in 2024. This was due to rising chronic conditions needing quick diagnosis, advances in healthcare technology, and the presence of key companies. More FDA approvals for new products also aid market growth. For example, in May 2022, empowerDX launched an at-home celiac disease genetic risk test. The kits offer molecular testing and deliver accurate results.



Market Competitive Landscape:
The self-testing sector is varied, with companies providing solutions for a wide range of health metrics, including blood glucose, cholesterol, infectious diseases, fertility, and genetic testing. The market is characterized by continuous innovation, technical breakthroughs, and a growing emphasis on offering consumers with user-friendly, accurate, and accessible testing alternatives. F. Hoffmann-La Roche Ltd., Becton, Dickinson and Company, Abbott Laboratories, Quidel Corporation, Johnson & Johnson Services, Inc, and Piramal Enterprises Ltd, among others, have a strong presence in the market.

Recent Developments:
  • The World Health Organization (WHO) prequalified the OraQuick HCV self-test, made by OraSure Technologies, in July 2024, to improve access to hepatitis C testing and diagnosis. This self-test is based on the OraQuick HCV Rapid Antibody Test.
  • In September 2024, Mankind Pharma announced rapid self-test kits to tackle important health issues in India. These kits provide fast and accurate results for various health conditions, increasing access to healthcare services and supporting public health management.
Scope of the Report:
 Report Metric Details
 Market size available for years 2021-2034
 Base year considered 2024
 Forecast period 2025-2034
 Segments coveredBy Product, By Sample, By Application, By Distribution Channel.
 Regions covered
North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa.
 Companies CoveredGeratherm Medical AG, Cardinal Health, OraSure Technologies, Inc, bioLytical Laboratories Inc, PRIMA Lab SA, BD, F. Hoffmann-La Roche Ltd, Bionime Corporation, Abbott, Everlywell, Inc. and others.
Key Topics Covered in the Report:
  • Global Self-testing Market Size (FY’2021-FY’2034)
  • Overview of Global Self-testing Market
  • Segmentation of Global Self-testing Market By Product (Kits, Devices, Strips)
  • Segmentation of Global Self-testing Market By Test Type (Blood, Urine, Stool, Others)
  • Segmentation of Global Self-testing Market By Application (Blood Pressure Test, Diabetes and Glucose Tests, Cholesterol and Triglycerides Tests, Pregnancy Test, STD /STI Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Others)
  • Segmentation of Global Self-testing Market By Distribution Channel (Online, Offline)
  • Statistical Snap of Global Self-testing Market
  • Expansion Analysis of Global Self-testing Market
  • Problems and Obstacles in Global Self-testing Market
  • Competitive Landscape in the Global Self-testing Market
  • Details on Current Investment in Global Self-testing Market
  • Competitive Analysis of Global Self-testing Market
  • Prominent Players in the Global Self-testing Market
  • SWOT Analysis of Global Self-testing Market
  • Global Self-testing Market Future Outlook and Projections (FY’2025-FY’2034)
  • Recommendations from Analyst
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPERs internal database
2.1.4. Premium insight from KOLs
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation

3. Executive Summary

4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges

5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTERs Five Forces 
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis

6. Competitive Landscape
6.1. Global Self-testing Market Manufacturing Base Distribution, Sales Area, Product Type 
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Self-testing Market

7. Global Self-testing Market, By Product (USD Million) 2021-2034
7.1. Kits
7.2. Devices
7.3. Strips

8. Global Self-testing Market, By Sample (USD Million) 2021-2034
8.1. Blood
8.2. Urine
8.3. Stool
8.4. Others

9. Global Self-testing Market, By Application (USD Million) 2021-2034
9.1. Blood Pressure Test
9.2. Diabetes and Glucose Tests
9.3. Cholesterol and Triglycerides Tests
9.4. Pregnancy Test
9.5. STD /STI Test
9.6. Urinary Tract Infection Test
9.7. Cancer Test
9.8. Celiac disease Test
9.9. Thyroid Test
9.10. Transaminase Test
9.11. Anemia Test
9.12. Allergy Test
9.13. Others

10. Global Self-testing Market, By Distribution Channel (USD Million) 2021-2034
10.1. Online
10.2. Offline

11. Global Self-testing Market, (USD Million) 2021-2034
11.1. Global Self-testing Market Size and Market Share

12. Global Self-testing Market, By Region, (USD Million) 2021-2034
12.1. Asia-Pacific
12.1.1. Australia
12.1.2. China
12.1.3. India
12.1.4. Japan
12.1.5. South Korea
12.1.6. Rest of Asia-Pacific
12.2. Europe
12.2.1. France
12.2.2. Germany
12.2.3. Italy
12.2.4. Spain
12.2.5. United Kingdom
12.2.6. Rest of Europe
12.3. Middle East and Africa
12.3.1. Kingdom of Saudi Arabia 
12.3.2. United Arab Emirates
12.3.3. Qatar
12.3.4. South Africa
12.3.5. Egypt
12.3.6. Morocco
12.3.7. Nigeria
12.3.8. Rest of Middle-East and Africa
12.4. North America
12.4.1. Canada
12.4.2. Mexico
12.4.3. United States
12.5. Latin America
12.5.1. Argentina
12.5.2. Brazil
12.5.3. Rest of Latin America 

13. Company Profile
13.1. Geratherm Medical AG
13.1.1. Company details
13.1.2. Financial outlook
13.1.3. Product summary 
13.1.4. Recent developments
13.2. Cardinal Health
13.2.1. Company details
13.2.2. Financial outlook
13.2.3. Product summary 
13.2.4. Recent developments
13.3. OraSure Technologies, Inc
13.3.1. Company details
13.3.2. Financial outlook
13.3.3. Product summary 
13.3.4. Recent developments
13.4. bioLytical Laboratories Inc
13.4.1. Company details
13.4.2. Financial outlook
13.4.3. Product summary 
13.4.4. Recent developments
13.5. PRIMA Lab SA
13.5.1. Company details
13.5.2. Financial outlook
13.5.3. Product summary 
13.5.4. Recent developments
13.6. BD
13.6.1. Company details
13.6.2. Financial outlook
13.6.3. Product summary 
13.6.4. Recent developments
13.7. F. Hoffmann-La Roche Ltd
13.7.1. Company details
13.7.2. Financial outlook
13.7.3. Product summary 
13.7.4. Recent developments
13.8. Bionime Corporation
13.8.1. Company details
13.8.2. Financial outlook
13.8.3. Product summary 
13.8.4. Recent developments
13.9. Abbott
13.9.1. Company details
13.9.2. Financial outlook
13.9.3. Product summary 
13.9.4. Recent developments
13.10. Everlywell, Inc
13.10.1. Company details
13.10.2. Financial outlook
13.10.3. Product summary 
13.10.4. Recent developments
13.11. Others

14. Conclusion

15. List of Abbreviations

16. Reference Links

SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.

The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings.  The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.

SPER-Methodology-1

SPER-Methodology-2

SPER-Methodology-3


Frequently Asked Questions About This Report
Self-testing Market is projected to reach USD 31.41 billion by 2034, growing at a CAGR of 6.95% during the forecast period.
Self-testing Market grew in Market size from 2025. The Market is expected to reach USD 31.41 billion by 2034, at a CAGR of 6.95% during the forecast period.
Self-testing Market CAGR of 6.95% during the forecast period.
You can get the sample pages by clicking the link - Click Here
Self-testing Market size is USD 31.41 billion from 2025 to 2034.
Self-testing Market is covered By Product, By Sample, By Application, By Distribution Channel.
The North America is anticipated to have the highest Market share in the Self-testing Market.
The key players in the Market include Companies Covered Geratherm Medical AG, Cardinal Health, OraSure Technologies, Inc, bioLytical Laboratories Inc, PRIMA Lab SA, BD, F. Hoffmann-La Roche Ltd, Bionime Corporation, Abbott, Everlywell, Inc. and others.
The expanding emphasis on preventative healthcare encourages people to check their health on a regular basis, increasing the need for self-testing as a proactive approach to well-being.
PLACE AN ORDER
  • 15 % off
     
    $ 4250
  • 20 % off
             
    $ 5650
  • 25 % off
         
    $ 7450
Pre-Purchase Inquiry
SEND AN INQUIRY
NEED CUSTOMIZATION?
Request Customization
CALL OR EMAIL US
US:
India:
Email:
100% Secure Payment

SPER American Express
SPER VISA
SPER Master Card
SPER Mestro
SPER Paypal
SPER CCAvenues

Have a glance of the Report

  Download Free Sample

Looking for Customization?

 Customization Request

Have a Question?

 Reach Our Analysis Team

COVID-19 impact analysis?

 Request Analysis

Our Global Clients

Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.

SPER-Astellas Pharma
SPER-Microsoft
SPER-EY
SPER-McKinsey
SPER-Bain
SPER-Max-Healthcare
SPER-DHL
SPER-IQVIA
SPER-Mitsubishi Logistics
SPER-PACCOR
SPER-Macmillan Education
SPER-Kankar IMRB
SPER-ITA
SPER-PWC
SPER-SAPTCA
SPER-Straumann
SPER-MENARINI Silicon Biosystems
SPER-IPSOS
SPER-Heineken

GDPR
Complaint

ISO 27001, 20252 & 9001
Certified